Sergio Ruiz
Fondatore presso Methuselah Capital Management LLC
Profilo
Mr. Sergio Ruiz is a Chief Operating Officer at Turn Biotechnologies, Inc., a Senior Advisor at Oisin Biotechnologies, Inc. and a Co- Founder & Managing Director at Methuselah Capital Management LLC.
He is on the Board of Directors at Leucadia Therapeutics, Inc. Mr. Ruiz was previously employed as a Senior Advisor by Volumetric, Inc. He received his undergraduate degree from the University of Maryland.
Posizioni attive di Sergio Ruiz
| Società | Posizione | Inizio |
|---|---|---|
Turn Biotechnologies, Inc.
 Turn Biotechnologies, Inc. BiotechnologyHealth Technology Turn Biotechnologies, Inc. engages in the development of solutions for reversing aging and age-related diseases. It focuses on achieving rejuvenation across cellular aging hallmarks in human fibroblasts and endothelial cells without the loss cellular identity. The company was founded by Jay Sarkar, Marco Quarta, and Vittorio Sebastiano and is headquartered in Mountain View, CA. | Direttore operativo | 01/09/2018 |
Methuselah Capital Management LLC
 Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management LLC (Methuselah Fund) is a venture capital firm, a subsidiary of Methuselah Foundation founded in 2016 by Sergio Ruiz and David Gobel. The firm is headquartered in Springfield, Virginia. | Fondatore | 01/01/2016 |
Leucadia Therapeutics, Inc.
 Leucadia Therapeutics, Inc. Medical SpecialtiesHealth Technology Leucadia Therapeutics, Inc. develops diagnostic algorithm for Alzheimer disease prevention and treatment. The firm?s therapeutic device is under pre-clinical testing to delay or prevent patients with mild cognitive impairment (MCI) from progressing to Alzheimer's disease. The company was founded by Doug Ethell and is headquartered in Delaware. | Direttore/Membro del Consiglio | 01/03/2017 |
Oisin Biotechnologies, Inc.
 Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Oisin Biotechnologies, Inc. operates as a drug development company. It engages in the provision of biological solutions to degenerative aging conditions. The company was founded by Gary Hudson, Kevin Perrott, Matthew Scholz and John Lewis in 2014 and is headquartered in Seattle, WA. | Consulente / Consigliere | 01/12/2016 |
Precedenti posizioni note di Sergio Ruiz
| Società | Posizione | Fine |
|---|---|---|
Volumetric, Inc.
 Volumetric, Inc. Internet RetailRetail Trade Volumetric, Inc. is engaged in improving the quality and length of human health through engineering vascularized tissue. Its bioprinters and bio-inks are used for applications in the life sciences, drug discovery, and medical devices. The company was founded by Jordan s. Miller and Bagrat Grigoryan in 2018 and is headquartered in Houston, TX. | Consulente / Consigliere | 01/12/2021 |
Formazione di Sergio Ruiz
| University of Maryland | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Oisin Biotechnologies, Inc.
Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Oisin Biotechnologies, Inc. operates as a drug development company. It engages in the provision of biological solutions to degenerative aging conditions. The company was founded by Gary Hudson, Kevin Perrott, Matthew Scholz and John Lewis in 2014 and is headquartered in Seattle, WA. | Health Technology |
Methuselah Capital Management LLC
Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management LLC (Methuselah Fund) is a venture capital firm, a subsidiary of Methuselah Foundation founded in 2016 by Sergio Ruiz and David Gobel. The firm is headquartered in Springfield, Virginia. | Finance |
Leucadia Therapeutics, Inc.
Leucadia Therapeutics, Inc. Medical SpecialtiesHealth Technology Leucadia Therapeutics, Inc. develops diagnostic algorithm for Alzheimer disease prevention and treatment. The firm?s therapeutic device is under pre-clinical testing to delay or prevent patients with mild cognitive impairment (MCI) from progressing to Alzheimer's disease. The company was founded by Doug Ethell and is headquartered in Delaware. | Health Technology |
Volumetric, Inc.
Volumetric, Inc. Internet RetailRetail Trade Volumetric, Inc. is engaged in improving the quality and length of human health through engineering vascularized tissue. Its bioprinters and bio-inks are used for applications in the life sciences, drug discovery, and medical devices. The company was founded by Jordan s. Miller and Bagrat Grigoryan in 2018 and is headquartered in Houston, TX. | Retail Trade |
Turn Biotechnologies, Inc.
Turn Biotechnologies, Inc. BiotechnologyHealth Technology Turn Biotechnologies, Inc. engages in the development of solutions for reversing aging and age-related diseases. It focuses on achieving rejuvenation across cellular aging hallmarks in human fibroblasts and endothelial cells without the loss cellular identity. The company was founded by Jay Sarkar, Marco Quarta, and Vittorio Sebastiano and is headquartered in Mountain View, CA. | Health Technology |
- Borsa valori
- Insiders
- Sergio Ruiz
